Skip to main content
Fig. 1 | Molecular Cancer

Fig. 1

From: Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

Fig. 1

Network analysis for association with pCR and iDFS. A Pathway enrichment analysis for 121 genes whose differential expression was associated with pCR outcomes identified significant enrichment for immune system processes and viral genome regulation. B Pathway enrichment analysis for 728 genes whose differential expression was associated with iDFS outcomes identified enrichment for cytoplasmic and protein-binding cellular processes

Back to article page

Molecular Cancer

ISSN: 1476-4598